Valeant Pharmaceuticals International, Biovail Corporation to Cut 25 Pct Jobs Of Combined Company

Published: Sep 07, 2010

Sept 7 (Reuters) - U.S.-based Valeant Pharmaceuticals International (VRX.N), which agreed to be bought by Canada's Biovail Corp (BVF.TO) in June, said they would cut about 25 percent of the combined company's U.S. and Canadian workforce as part of the integration plans.

Back to news